Market
What will be the stance of medical organizations on UK puberty blockers ban by mid-2025?
2
Resolution / Starting Odds
Support the ban • 25%
Oppose the ban • 25%
Call for more research • 25%
Remain neutral • 25%
Statements or publications from major medical organizations like the British Medical Association or Royal College of Paediatrics and Child Health
Story
UK Government Announces Indefinite Ban on Puberty Blockers for Under-18s
Dec 11, 2024, 02:44 PM
The UK government has announced an indefinite ban on the prescription of puberty blockers for children under 18 with gender dysphoria, effective from January 1, 2025. This decision follows a temporary ban introduced in May 2024, which was based on the findings of the Cass Review that highlighted insufficient evidence regarding the safety of these medications. Health Secretary Wes Streeting made the announcement, stating that the ban would apply to all prescriptions outside of clinical trials. The move aims to prevent what experts have described as an 'unacceptable safety risk' to minors. The government is also working with NHS England to provide holistic support for patients and their families, while the ban extends to private UK-registered prescribers as well.
View original story
Similar markets
Yes • 50%
No • 50%
Mermaids • 25%
British Medical Association • 25%
Other • 25%
Stonewall • 25%
No clear majority • 25%
Majority neutral/undecided • 25%
Majority oppose the ban • 25%
Majority support the ban • 25%
Less supportive of the ban • 25%
More supportive of the ban • 25%
No significant change • 25%
Divided opinion • 25%
Ban is lifted • 25%
New restrictions added • 25%
Ban remains unchanged • 25%
Ban is modified • 25%
LGBTQ+ advocacy groups • 25%
Parents of transgender youth • 25%
Other • 25%
Medical professionals • 25%
Safe and effective • 25%
Unsafe • 25%
Inconclusive • 25%
Trial not completed • 25%
No clear majority • 25%
Majority support ban • 25%
Majority oppose ban • 25%
Opinion evenly split • 25%